Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1477-3155

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis ; volume:8 ; number:1 ; day:24 ; month:9 ; year:2010 ; pages:1-18 ; date:12.2010
Journal of nanobiotechnology ; 8, Heft 1 (24.9.2010), 1-18, 12.2010

Creator: Vij, Neeraj

Contributor: Min, Taehong
Marasigan, Rhul
Belcher, Christopher N.
Mazur, Steven
Ding, Hong
Yong, Ken-Tye
Roy, Indrajit
SpringerLink (Online service)

DOI: 10.1186/1477-3155-8-22

URN: urn:nbn:de:1111-2016073038482

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vij, Neeraj
Min, Taehong
Marasigan, Rhul
Belcher, Christopher N.
Mazur, Steven
Ding, Hong
Yong, Ken-Tye
Roy, Indrajit
SpringerLink (Online service)

Other Objects (12)

Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA

Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response

Attenuation of skin injury by a MARCO targeting PLGA nanoparticle

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

Hochschulschrift

PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

Insight into Fucoidan-based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-inflammatory Study

Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA

Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response

Attenuation of skin injury by a MARCO targeting PLGA nanoparticle

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

Hochschulschrift

PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

Insight into Fucoidan-based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-inflammatory Study

Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA

Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response

Attenuation of skin injury by a MARCO targeting PLGA nanoparticle

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

Hochschulschrift

PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

Insight into Fucoidan-based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-inflammatory Study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA

Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response

Attenuation of skin injury by a MARCO targeting PLGA nanoparticle

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

Insight into Fucoidan-based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-inflammatory Study

Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA

Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response

Attenuation of skin injury by a MARCO targeting PLGA nanoparticle

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

Insight into Fucoidan-based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-inflammatory Study

Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA

Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response

Attenuation of skin injury by a MARCO targeting PLGA nanoparticle

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

Insight into Fucoidan-based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-inflammatory Study

Related objects

Reset password